doi: 10.1016/j.cmet.2021.06.014 Summary Keywords chronic kidney disease, gut-brain-kidney axis, gut microbiota, metabolites, therapy Citation Zhu J, Fu Y, Olovo CV, Xu J, Wu Q, Wei W, Jiang K and Zheng X (2025) The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease
VaduganathanMSathiyakumarVSinghAMcCarthyCPQamarAJanuzziJLet al., et al
The 2018 and 2021 ACG position papers recommend TCA use for overall symptom improvement, while SSRIs are only weakly suggested in the 2018 guidelines, based on the low quality of evidence for their use
Future of IV glutathione and B-12 shots still unsettled in California Crystal A
There are a lot of side effects that people on weight-loss medications experience because of not getting the nutrients they need, said Zwolinski
Abstract Reduced glutathione, most commonly called glutathione or GSH, is a relatively small molecule ubiquitous in living systems.1-3 Occurring naturally in all human cells, GSH is a water-phase orthomolecular